FilippiMRoccaMACalabreseM. Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis. Neurology2010; 75: 1988–1994.
6.
FisherELeeJCNakamuraK. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol2008; 64: 255–265.
7.
AmatoMPBartolozziMLZipoliV. Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment. Neurology2004; 63: 89–93.
8.
SanfilipoMPBenedictRHWeinstock-GuttmanB. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology2006; 66: 685–692.
9.
ChenJTNarayananSCollinsDL. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage2004; 23: 1168–1175.
10.
FisnikuLKChardDTJacksonJS. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol2008; 64: 247–254.
11.
SicotteNLKernKCGiesserBS. Regional hippocampal atrophy in multiple sclerosis. Brain2008; 131: 1134-1141.
12.
GoldSMKernKCO’ConnorMF. Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms. Biol Psychiatry68: 553–559.
13.
AndersonVFisnikuLAltmannD. MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction. Mult Scler2009; 15: 811–817.
14.
RoccaMAMesarosSPaganiE. Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology2010; 257: 463–469.
15.
FilippiMRoccaMA. MR Imaging of Multiple Sclerosis. Radiology2011; 259: 659–681.
